Wix market cap overtakes Teva
Although Teva's share price rose 4.06% on Wall Street on Friday, the Israeli pharmaceutical company's market cap still finished the week below the fast-growing DIY website company.
US Congress heaps more misery on Teva
Teva fell over 10% on a bearish Wall Street after Congress members accused it of obstructing a price-fixing probe and Moody's revised its outlook to negative.
Landa: I see Teva being broken up
Benny Landa, who sold off his Teva holding two years ago, traces the company's troubles to the "idiotic" firing of CEO Jeremy Levin.
After Ori Yehudai's about face at cannabis company Sade, Amit Sade talks about what happened, and what makes his company different.
Good bacteria, bad products
Microbiome pioneer Prof. Gregor Reid sees vast potential in probiotics for our helath but dismisses 90% of the products sold on the market as useless.